BGI Genomics Co., Ltd. (SHE:300676)
53.23
+2.17 (4.25%)
Sep 8, 2025, 11:34 AM CST
BGI Genomics Market Cap
BGI Genomics has a market cap or net worth of 19.60 billion as of September 5, 2025. Its market cap has increased by 43.32% in one year.
Market Cap
19.60B
Enterprise Value
16.51B
Revenue
3.63B
Ranking
n/a
PE Ratio
n/a
Stock Price
53.23
Market Cap Chart
Since July 14, 2017, BGI Genomics's market cap has increased from 7.86B to 19.60B, an increase of 149.42%. That is a compound annual growth rate of 11.87%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 5, 2025 | 19.60B | 22.45% |
Dec 31, 2024 | 16.01B | -18.66% |
Dec 29, 2023 | 19.68B | -7.14% |
Dec 30, 2022 | 21.19B | -41.13% |
Dec 31, 2021 | 35.99B | -29.32% |
Dec 31, 2020 | 50.92B | 85.26% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Jul 14, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Jiangsu Hengrui Medicine | 482.35B |
WuXi AppTec | 313.22B |
Shenzhen Mindray Bio-Medical Electronics | 287.79B |
Sichuan Biokin Pharmaceutical | 155.60B |
Zhangzhou Pientzehuang Pharmaceutical., | 123.00B |
Aier Eye Hospital Group | 120.10B |
Shanghai United Imaging Healthcare | 116.97B |
Yunnan Baiyao Group Co.,Ltd | 105.81B |